GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Short-Term Capital Lease Obligation

Curocell (XKRX:372320) Short-Term Capital Lease Obligation : ₩521.26 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Short-Term Capital Lease Obligation?

Curocell's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was ₩521.26 Mil.

Curocell's quarterly Short-Term Capital Lease Obligation increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩543.92 Mil) but then declined from Dec. 2022 (₩543.92 Mil) to Jun. 2023 (₩521.26 Mil).

Curocell's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (₩510.64 Mil) to Dec. 2022 (₩543.92 Mil) but then declined from Dec. 2022 (₩543.92 Mil) to Dec. 2023 (₩502.31 Mil).

Curocell Short-Term Capital Lease Obligation Historical Data

The historical data trend for Curocell's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Short-Term Capital Lease Obligation Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
469.84 510.71 510.64 543.92 502.31

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Short-Term Capital Lease Obligation - 543.92 521.26 502.31

Curocell Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Curocell Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Curocell's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines